Today@Dal

» Go to news main

Canadian Center for Vaccinology rotavirus vaccine study

Posted by Pediatrics/Canadian Center for Vaccinology on October 2, 2019 in General Announcements

Rotavirus (RV) infection is the leading cause of severely inflamed stomach or gut (gastroenteritis [GE]) and severe diarrhea in infants and young children less than 5 years of age. Over the last few decades, the development of vaccines has been beneficial to prevent deaths due to RV infection.

The types of vaccines against Rotavirus infection currently manufactured by GSK are:

  1. Licensed Rotarix (lyophilized – freeze dried powder that is mixed with a liquid)
  2. PCV-free HRV vaccine (liquid)
  3. Licensed Rotarix (liquid)

In this study, GSK will compare the safety profile of the first 2 vaccines mentioned above in infants.

We are looking for healthy infants aged 6-12 weeks old to take part in this clinical research study. For more information, visit our website here: http://centerforvaccinology.ca/study/infant-rotavirus-study/

Contact
information: Pamela MacIntyre

                                      
902-470-8948

                                       pamela.macintyre@iwk.nshealth.ca